The DOI matches its Crossref record; 316 of the 316 references it cites were found in a registry or an index.
Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Open accessAbstract
Cells require tight regulation of the intracellular redox balance and consequently of reactive oxygen species for proper redox signaling and maintenance of metal (e.g., of iron and copper) homeostasis. In several diseases, including cancer, this balance is disturbed. Therefore, anticancer drugs targeting the redox systems, for example, glutathione and thioredoxin, have entered focus of interest. Anticancer metal complexes (platinum, gold, arsenic, ruthenium, rhodium, copper, vanadium, cobalt, manganese, gadolinium, and molybdenum) have been shown to strongly interact with or even disturb cellular redox homeostasis. In this context, especially the hypothesis of "activation by reduction" as well as the "hard and soft acids and bases" theory with respect to coordination of metal ions to cellular ligands represent important concepts to understand the molecular modes of action of anticancer metal drugs. The aim of this review is to highlight specific interactions of metal-based anticancer drugs with the cellular redox homeostasis and to explain this behavior by considering chemical properties of the respective anticancer metal complexes currently either in (pre)clinical development or in daily clinical routine in oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chatterjee, S., Mookerjee, A., Basu, J. M., Chakraborty, P., Ganguly, A., Adhikary, A., Mukhopadhyay, D., Ganguli, S., Banerjee, R., Ashraf, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007048 · Cited by 46
RetractedCRC Handbook of Chemistry and Physics
(2014) · doi:10.1201/b17118 · Cited by 57,706
Electrochemical Methods: Fundamentals and Applications
Bard, A. J., & Faulkner, L. R. (1980) · Cited by 22,822
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Electrochemical Methods: Fundamentals and Applications
de Rooij, D. M. R. (2003) · Anti-Corrosion Methods and Materials · doi:10.1108/acmm.2003.12850eae.001 · Cited by 13,009
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 1×
“It consists of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor), which is tightly bound to the actin-binding protein Keap1 (kelch-like ECH-associated protein) in unstressed cells (170).”
Glutathione: overview of its protective roles, measurement, and biosynthesis
Forman, H. J., Zhang, H., & Rinna, A. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.006 · Cited by 2,636
The catalytic decomposition of hydrogen peroxide by iron salts
Haber, F., & Weiss, J. (1934) · Proceedings of the Royal Society of London. Series A - Mathematical and Physical Sciences · doi:10.1098/rspa.1934.0221 · Cited by 2,571
The Pecking Order of Free Radicals and Antioxidants: Lipid Peroxidation, α-Tocopherol, and Ascorbate
Buettner, G. R. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1074 · Cited by 2,417
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Kim, I., Xu, W., & Reed, J. C. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2755 · Cited by 1,817
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J. D., & Kaufman, R. J. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,563
Pavlishchuk, V. V., & Addison, A. W. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(99)00407-7 · Cited by 1,518
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Rhee, S. G., Chae, H. Z., & Kim, K. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.026 · Cited by 1,409
Generation of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260 · cited 1×
“The most redox-active parts of the cell are the mitochondria, which consequently are also the major intracellular generators of ROS (221).”
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms
Beyersmann, D., & Hartwig, A. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0313-y · Cited by 1,206
Analysis of glutathione: implication in redox and detoxification
Pastore, A., Federici, G., Bertini, E., & Piemonte, F. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00200-6 · Cited by 1,186
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
Bioorganometallic chemistry—from teaching paradigms to medicinal applications
Hartinger, C. G., & Dyson, P. J. (2009) · Chem. Soc. Rev. · doi:10.1039/b707077m · Cited by 985
Self-citationHartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.013 · Cited by 956
Self-citationLever, A. B. P. (1990) · Inorganic Chemistry · doi:10.1021/ic00331a030 · Cited by 929
Sigman, D. S., Mazumder, A., & Perrin, D. M. (1993) · Chemical Reviews · doi:10.1021/cr00022a011 · Cited by 921
Regulation of superoxide dismutase genes: Implications in disease
Miao, L., & St. Clair, D. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.018 · Cited by 912
Non-Platinum Chemotherapeutic Metallopharmaceuticals
Clarke, M. J., Zhu, F., & Frasca, D. R. (1999) · Chemical Reviews · doi:10.1021/cr9804238 · Cited by 908
Catalytic Metals, Ascorbate and Free Radicals: Combinations to Avoid
Buettner, G. R., & Jurkiewicz, B. A. (1996) · Radiation Research · doi:10.2307/3579271 · Cited by 887
Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839
Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3852 · Cited by 826
Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate
Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsaprailis, G., Gresser, M. J., & Ramachandran, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.843 · Cited by 815
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Chen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775
Proceedings of the American Association for Cancer Research.
Konings, E. J. M., van den Brandt, P. A., Saris, W. H. M., Brants, H. A. M., & Goldbohm, R. A. (2001) · Cited by 764
The Steap proteins are metalloreductases
Ohgami, R. S., Campagna, D. R., McDonald, A., & Fleming, M. D. (2006) · Blood · doi:10.1182/blood-2006-02-003681 · Cited by 744
Apoptosis and glutathione: beyond an antioxidant
Franco, R., & Cidlowski, J. A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.107 · Cited by 744
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Self-citationMonomethylarsonous Acid (MMAIII) Is More Toxic Than Arsenite in Chang Human Hepatocytes
Petrick, J. S., Ayala-Fierro, F., Cullen, W. R., Carter, D. E., & Vasken Aposhian, H. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8872 · Cited by 716
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential
Paine, A., Eiz-Vesper, B., Blasczyk, R., & Immenschuh, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.014 · Cited by 699
Ruthenium metallopharmaceuticals
Clarke, M. J. (2003) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00312-0 · Cited by 687
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
Mechanisms of resistance to cisplatin and carboplatin
Stewart, D. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.02.001 · Cited by 631
Protein S-glutathionylation: a regulatory device from bacteria to humans
Dalle-Donne, I., Rossi, R., Colombo, G., Giustarini, D., & Milzani, A. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.11.002 · Cited by 628
Redox compartmentalization in eukaryotic cells
Go, Y.-M., & Jones, D. P. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.01.011 · Cited by 626
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
The Endoplasmic Reticulum: Folding, Calcium Homeostasis, Signaling, and Redox Control
Görlach, A., Klappa, P., & Kietzmann, D. T. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1391 · Cited by 615
Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 614
Self-citationEvangelou, A. M. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00221-9 · Cited by 612
Non Platinum Metal Complexes as Anti‐cancer Drugs
Ott, I., & Gust, R. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600151 · Cited by 609
The thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589
Fenton Chemistry: An Introduction
Wardman, P., & Candeias, L. P. (1996) · Radiation Research · doi:10.2307/3579270 · Cited by 587
Meyers, C. A., Smith, J. A., Bezjak, A., Mehta, M. P., Liebmann, J., Illidge, T., Kunkler, I., Caudrelier, J.-M., Eisenberg, P. D., Meerwaldt, J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.128 · Cited by 585
Aird, R. E., Cummings, J., Ritchie, A. A., Muir, M., Morris, R. E., Chen, H., Sadler, P. J., & Jodrell, D. I. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600290 · Cited by 582
Structure of the human transferrin receptor-transferrin complex
Cheng, Y., Zak, O., Aisen, P., Harrison, S. C., & Walz, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00130-8 · Cited by 571 · cited 1×
“At the slightly alkaline pH of 7.4, Tf can bind one or two ferric ions with an overall blood iron load of 30% (69).”
InfluentialArredondo, M., & Núñez, M. T. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.010 · Cited by 550
Free radical biology and medicine
(2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00484-2 · Cited by 549
Early Embryonic Lethality Caused by Targeted Disruption of the Mouse Thioredoxin Gene
Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0208 · Cited by 546 · cited 1×
“Interestingly, knock-out mice for all Trx/TrxR genes are lethal during embryogenesis (240, 275), indicating the wide-spread and essential regulatory functions of the Trx/TrxR system in mammalian cells and tissues.”
Jing, Y., Dai, J., Chalmers-Redman, R. M. E., Tatton, W. G., & Waxman, S. (1999) · Blood · doi:10.1182/blood.v94.6.2102 · Cited by 543
Dai, J., Weinberg, R. S., Waxman, S., & Jing, Y. (1999) · Blood · doi:10.1182/blood.v93.1.268 · Cited by 540
Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
Hayes, J. D., McMahon, M., Chowdhry, S., & Dinkova-Kostova, A. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3221 · Cited by 539
Ferritin and the response to oxidative stress
ORINO, K., LEHMAN, L., TSUJI, Y., AYAKI, H., TORTI, S. V., & TORTI, F. M. (2001) · Biochemical Journal · doi:10.1042/bj3570241 · Cited by 535
Labile iron pool: the main determinant of cellular response to oxidative stress
Kruszewski, M. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.004 · Cited by 533
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling
Cox, A. G., Winterbourn, C. C., & Hampton, M. B. (2010) · Biochemical Journal · doi:10.1042/bj20091541 · Cited by 532
Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential
Batinić-Haberle, I., Rebouças, J. S., & Spasojević, I. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2876 · Cited by 531
Sigman, D. S., Graham, D. R., D'Aurora, V., & Stern, A. M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86305-6 · Cited by 528
Intracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526
Hayakawa, T., Kobayashi, Y., Cui, X., & Hirano, S. (2005) · Archives of Toxicology · doi:10.1007/s00204-004-0620-x · Cited by 524
Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation
Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523
1,10-Phenanthroline: a versatile ligand
Sammes, P. G., & Yahioglu, G. (1994) · Chemical Society Reviews · doi:10.1039/cs9942300327 · Cited by 518
Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling
Mandic, A., Hansson, J., Linder, S., & Shoshan, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210284200 · Cited by 509
Controlling Tumor Growth by Modulating Endogenous Production of Reactive Oxygen Species
Laurent, A., Nicco, C., Chéreau, C., Goulvestre, C., Alexandre, J., Alves, A., Lévy, E., Goldwasser, F., Panis, Y., Soubrane, O., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.948.65.3 · Cited by 509
New developments and novel therapeutic perspectives for vitamin C
Li, Y., & Schellhorn, H. E. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.10.2171 · Cited by 508
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Knox, R. J., Friedlos, F., Lydall, D. A., & Roberts, J. J. (1986) · PubMed · Cited by 498
Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity
Chirino, Y. I., & Pedraza-Chaverri, J. (2009) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2008.09.003 · Cited by 489
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
Wondrak, G. T. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2541 · Cited by 462 · cited 4×
“The M40403 produced H 2 O 2 may especially target rapidly dividing cancer cells with impaired peroxide metabolism and high levels of endogenous oxidative stress (7, 208, 407).”
InfluentialMethionine in proteins defends against oxidative stress
Luo, S., & Levine, R. L. (2009) · The FASEB Journal · doi:10.1096/fj.08-118414 · Cited by 461
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Vitamin C: Update on physiology and pharmacology
Mandl, J., Szarka, A., & Bánhegyi, G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00282.x · Cited by 451
Transferrin/transferrin receptor‐mediated drug delivery
Li, H., & Qian, Z. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10008 · Cited by 441
Nonn, L., Williams, R. R., Erickson, R. P., & Powis, G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.916-922.2003 · Cited by 438
Structure, function, and mechanism of ribonucleotide reductases
Kolberg, M., Strand, K. R., Graff, P., & Andersson, K. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.02.007 · Cited by 437
Tumour-inhibiting platinum complexes—state of the art and future perspectives
Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 434
Self-citationHu, J., Liu, Y.-F., Wu, C.-F., Xu, F., Shen, Z.-X., Zhu, Y.-M., Li, J.-M., Tang, W., Zhao, W.-L., Wu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813280106 · Cited by 425
Villeneuve, N. F., Lau, A., & Zhang, D. D. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3211 · Cited by 423
Yu, Y., Kalinowski, D. S., Kovacevic, Z., Siafakas, A. R., Jansson, P. J., Stefani, C., Lovejoy, D. B., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900552r · Cited by 397
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
Chaney, S. G., Campbell, S. L., Bassett, E., & Wu, Y. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.08.008 · Cited by 396
Cisplatin nephrotoxicity: molecular mechanisms.
Hanigan, M. H., & Devarajan, P. (2003) · PubMed · Cited by 390
Dilda, P. J., & Hogg, P. J. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.05.001 · Cited by 389
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Zitvogel, L., Kepp, O., Senovilla, L., Menger, L., Chaput, N., & Kroemer, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2891 · Cited by 387
DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity
Brabec, V., & Nováková, O. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.002 · Cited by 384
Vanadium—an element of atypical biological significance
Mukherjee, B., Patra, B., Mahapatra, S., Banerjee, P., Tiwari, A., & Chatterjee, M. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.01.009 · Cited by 379
Glutathione redox potential in response to differentiation and enzyme inducers
Kirlin, W. G., Cai, J., Thompson, S. A., Diaz, D., Kavanagh, T. J., & Jones, D. P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00145-8 · Cited by 358
Metals and metal compounds in cancer treatment.
Desoize, B. (2004) · PubMed · Cited by 349
Brewer, G. J., Dick, R. D., Grover, D. K., LeClaire, V., Tseng, M., Wicha, M. S., Pienta, K. J., Redman, B. G., Jahan, T. M., Sondak, V. K., et al. (2000) · PubMed · Cited by 347
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Howell, S. B., Safaei, R., Larson, C. A., & Sailor, M. J. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063172 · Cited by 344
The role of NF-κB in the regulation of cell stress responses
Wang, T., Zhang, X., & Li, J. J. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00058-9 · Cited by 343
Arsenic in the aetiology of cancer
Tapio, S., & Grosche, B. (2006) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2006.02.001 · Cited by 334
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Ballatori, N., Krance, S. M., Marchan, R., & Hammond, C. L. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.08.004 · Cited by 318
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., & Fregona, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509288 · Cited by 314
Glutathione peroxidases in different stages of carcinogenesis
Brigelius-Flohé, R., & Kipp, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.006 · Cited by 305
Catalytic organometallic anticancer complexes
Dougan, S. J., Habtemariam, A., McHale, S. E., Parsons, S., & Sadler, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800076105 · Cited by 303
Novel Role for Glutathione S-Transferase π
Townsend, D. M., Manevich, Y., He, L., Hutchens, S., Pazoles, C. J., & Tew, K. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805586200 · Cited by 298
Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage
Weissbach, H., Resnick, L., & Brot, N. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.004 · Cited by 294
Singh, S., Vrishni, S., Singh, B. K., Rahman, I., & Kakkar, P. (2010) · Free Radical Research · doi:10.3109/10715762.2010.507670 · Cited by 293
Prodrug strategies in cancer therapy
Denny, W. A. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01253-3 · Cited by 290
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Ishida, S., McCormick, F., Smith-McCune, K., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.011 · Cited by 288
Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy
Chen, H. H. W., & Kuo, M. T. (2010) · Metal-Based Drugs · doi:10.1155/2010/430939 · Cited by 287
Ribonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Ascorbic acid and carnitine biosynthesis
Rebouche, C. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1147s · Cited by 275
Zhu, X.-H., Shen, Y.-L., Jing, Y.-K., Cai, X., Jia, P.-M., Huang, Y., Tang, W., Shi, G.-Y., Sun, Y.-P., Dai, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.9.772 · Cited by 272
Ascorbic acid enhances arsenic trioxide–induced cytotoxicity in multiple myeloma cells
Grad, J. M., Bahlis, N. J., Reis, I., Oshiro, M. M., Dalton, W. S., & Boise, L. H. (2001) · Blood · doi:10.1182/blood.v98.3.805 · Cited by 271
Casini, A., Gabbiani, C., Sorrentino, F., Rigobello, M. P., Bindoli, A., Geldbach, T. J., Marrone, A., Re, N., Hartinger, C. G., Dyson, P. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006678 · Cited by 270
Self-citationReduction and Anticancer Activity of Platinum(IV) Complexes
Choi, S., Filotto, C., Bisanzo, M., Delaney, S., Lagasee, D., Whitworth, J. L., Jusko, A., Li, C., Wood, N. A., Willingham, J., et al. (1998) · Inorganic Chemistry · doi:10.1021/ic971047x · Cited by 270
Peroxiredoxin 1 and its role in cell signaling
Neumann, C. A., Cao, J., & Manevich, Y. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10242 · Cited by 267
Marcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266
Cisplatin Generates Superoxide Anion by Interaction with DNA in a Cell-Free System
Masuda, H., Tanaka, T., & Takahama, U. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2306 · Cited by 254
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
Gandin, V., Fernandes, A. P., Rigobello, M. P., Dani, B., Sorrentino, F., Tisato, F., Björnstedt, M., Bindoli, A., Sturaro, A., Rella, R., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.023 · Cited by 252
Glickstein, H., Ben El, R., Shvartsman, M., & Cabantchik, Z. I. (2005) · Blood · doi:10.1182/blood-2005-02-0460 · Cited by 249
Copper homeostasis in eukaryotes: Teetering on a tightrope
Balamurugan, K., & Schaffner, W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.001 · Cited by 249
The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy
Biaglow, J. E., & Miller, R. A. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.1.1434 · Cited by 245
Resistance against novel anticancer metal compounds: Differences and similarities
Heffeter, P., Jungwirth, U., Jakupec, M., Hartinger, C., Galanski, M. S., Elbling, L., Micksche, M., Keppler, B., & Berger, W. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.02.002 · Cited by 242
Self-citationAntitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.
Harding, M., & Mokdsi, G. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374066 · Cited by 233
Marshall, L. E., Graham, D. R., Reich, K. A., & Sigman, D. S. (1981) · Biochemistry · doi:10.1021/bi00505a003 · Cited by 231
Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy
Tonissen, K. F., & Di Trapani, G. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700492 · Cited by 230
Zakharyan, R. A., Sampayo-Reyes, A., Healy, S. M., Tsaprailis, G., Board, P. G., Liebler, D. C., & Aposhian, H. V. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010052h · Cited by 226
VASKENAPOSHIAN, H. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.10.027 · Cited by 225
Witte, A.-B., Anestål, K., Jerremalm, E., Ehrsson, H., & Arnér, E. S. J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.025 · Cited by 225
Finch, R. A., Liu, M.-C., Cory, A. H., Cory, J. G., & Sartorelli, A. C. (1999) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(98)00017-x · Cited by 223
Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence
Bishayee, A., Waghray, A., Patel, M. A., & Chatterjee, M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.030 · Cited by 222
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
Meijer, C., Mulder, N. H., Timmer‐Bosscha, H., Sluiter, W. J., Meersma, G. J., & de Vries, E. G. E. (1992) · PubMed · Cited by 216
Biosynthesis of cobalamin (vitamin B12): a bacterial conundrum
Raux, E., Schubert, H. L., & Warren*, M. J. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000670 · Cited by 214
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213
Martins, N. M., Santos, N. A. G., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2008) · Journal of Applied Toxicology · doi:10.1002/jat.1284 · Cited by 212
Ott, I., Schmidt, K., Kircher, B., Schumacher, P., Wiglenda, T., & Gust, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049326z · Cited by 207
Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
Alvarez, H. M., Xue, Y., Robinson, C. D., Canalizo-Hernández, M. A., Marvin, R. G., Kelly, R. A., Mondragón, A., Penner-Hahn, J. E., & O’Halloran, T. V. (2010) · Science · doi:10.1126/science.1179907 · Cited by 204
The role of metallothionein in oncogenesis and cancer prognosis
Pedersen, M. Ø., Larsen, A., Stoltenberg, M., & Penkowa, M. (2009) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2008.10.001 · Cited by 200
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
Kapitza, S., Pongratz, M., Jakupec, M. A., Heffeter, P., Berger, W., Lackinger, L., Keppler, B. K., & Marian, B. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0617-0 · Cited by 200
Self-citationAlexandre, J., Nicco, C., Chéreau, C., Laurent, A., Weill, B., Goldwasser, F., & Batteux, F. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj049 · Cited by 199
Tse, H. M., Milton, M. J., & Piganelli, J. D. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.10.029 · Cited by 198
Electron-transfer activated metal-based anticancer drugs
Reisner, E., Arion, V. B., Keppler, B. K., & Pombeiro, A. J. L. (2008) · Inorganica Chimica Acta · doi:10.1016/j.ica.2006.12.005 · Cited by 197
Self-citationProtection against zinc toxicity by metallothionein and zinc transporter 1
Palmiter, R. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401022101 · Cited by 194
Casini, A., Cinellu, M. A., Minghetti, G., Gabbiani, C., Coronnello, M., Mini, E., & Messori, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060436a · Cited by 194
Cellular pathways for transport and efflux of ascorbate and dehydroascorbate
Corti, A., Casini, A. F., & Pompella, A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.014 · Cited by 193 · cited 1×
“Especially in case of ascorbate and GSH, intracellular levels in the millimolar range have been reported (22, 81).”
Ware, D. C., Palmer, B. D., Wilson, W. R., & Denny, W. A. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00065a006 · Cited by 193
Wang, Y., He, Q.-Y., Sun, R. W.-Y., Che, C.-M., & Chiu, J.-F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2867 · Cited by 190
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future
Evens, A. M., Tallman, M. S., & Gartenhaus, R. B. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.01.011 · Cited by 189
Arsenic Methylation, Urinary Arsenic Metabolites and Human Diseases: Current Perspective
TSENG, C.-H. (2007) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500701201695 · Cited by 187
Rackham, O., Nichols, S. J., Leedman, P. J., Berners-Price, S. J., & Filipovska, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.022 · Cited by 186
Voltammetric evaluation of the effective acidities (pKa') for Broensted acids in aprotic solvents
Barrette, W. C., Johnson, H. W., & Sawyer, D. T. (1984) · Analytical Chemistry · doi:10.1021/ac00275a030 · Cited by 181
The mechanism of action of platinum anticancer agents—what do we really know about it?
Gibson, D. (2009) · Dalton Transactions · doi:10.1039/b918871c · Cited by 181
Arnér, E. S. J., Nakamura, H., Sasada, T., Yodoi, J., Holmgren, A., & Spyrou, G. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00698-0 · Cited by 178
Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Chen, D., Milacic, V., Frezza, M., & Dou, Q. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787582183 · Cited by 178
Breuer, W., Shvartsman, M., & Cabantchik, Z. I. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.010 · Cited by 175
Kuwabara, M., Yoon, C., Goyne, T., Thederahn, T., & Sigman, D. S. (1986) · Biochemistry · doi:10.1021/bi00371a023 · Cited by 175
Shao, J., Zhou, B., Di Bilio, A. J., Zhu, L., Wang, T., Qi, C., Shih, J., & Yen, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0384 · Cited by 174
Chemical Methods To Evaluate Antioxidant Ability
Liu, Z.-Q. (2010) · Chemical Reviews · doi:10.1021/cr900302x · Cited by 173
Reisner, E., Arion, V. B., Guedes da Silva, M. F. C., Lichtenecker, R., Eichinger, A., Keppler, B. K., Kukushkin, V. Y., & Pombeiro, A. J. L. (2004) · Inorganic Chemistry · doi:10.1021/ic049479c · Cited by 173
Self-citationIntracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
Heffeter, P., Böck, K., Atil, B., Reza Hoda, M. A., Körner, W., Bartel, C., Jungwirth, U., Keppler, B. K., Micksche, M., Berger, W., et al. (2010) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-010-0642-1 · Cited by 173
Self-citationAnestål, K., & Arnér, E. S. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210733200 · Cited by 172
Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation
Salvemini, D., Doyle, T. M., & Cuzzocrea, S. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340965 · Cited by 169
Wang, F., Xu, J., Habtemariam, A., Bella, J., & Sadler, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053387k · Cited by 169
Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects
Schuhmacher–Wolz, U., Dieter, H. H., Klein, D., & Schneider, K. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440802291505 · Cited by 169
Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit
Jeon, K.-I., Byun, M.-S., & Jue, D.-M. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.9 · Cited by 169
Ceruloplasmin and what it might do
Healy, J., & Tipton, K. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0687-7 · Cited by 167
Bernhardt, P. V., Sharpe, P. C., Islam, M., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801012z · Cited by 166
Santos, N. A. G., Bezerra, C. S. C., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0459-y · Cited by 165
Shimizu, Y., & Hendershot, L. M. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2501 · Cited by 165
Rhodium and its compounds as potential agents in cancer treatment
Katsaros, N., & Anagnostopoulou, A. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00222-0 · Cited by 165
Jakupec, M. A., Reisner, E., Eichinger, A., Pongratz, M., Arion, V. B., Galanski, M. S., Hartinger, C. G., & Keppler, B. K. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490742 · Cited by 164
Self-citationMilacic, V., & Dou, Q. P. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.01.032 · Cited by 163
Kowol, C. R., Trondl, R., Heffeter, P., Arion, V. B., Jakupec, M. A., Roller, A., Galanski, M. S., Berger, W., & Keppler, B. K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900528d · Cited by 162
Self-citationMotexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
Arsenicals Inhibit Thioredoxin Reductase in Cultured Rat Hepatocytes
Lin, S., Del Razo, L. M., Styblo, M., Wang, C., Cullen, W. R., & Thomas, D. J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0001878 · Cited by 162
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
Stordal, B., Pavlakis, N., & Davey, R. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.01.009 · Cited by 159
Molecular processes in cellular arsenic metabolism
Thomas, D. J. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.02.007 · Cited by 158
Ferrer‐Sueta, G., Batinic̈‐Haberle, I., Spasojević, I., Fridovich, I., & Radí, R. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980245d · Cited by 157
Don, A. S., Kisker, O., Dilda, P. J., Donoghue, N., Zhao, X., Decollogne, S., Creighton, B., Flynn, E. A., Folkman, J., & Hogg, P. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00109-0 · Cited by 156
Kopera, E., Schwerdtle, T., Hartwig, A., & Bal, W. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049842s · Cited by 155
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
Jiang, M., & Dong, Z. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139162 · Cited by 155
Becker, K., Herold‐Mende, C. C., Park, J. J., Lowe, G. M., & Schirmer, R. H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001014i · Cited by 150
Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes
Eastman, A. R. (1987) · Chemico-Biological Interactions · doi:10.1016/0009-2797(87)90004-4 · Cited by 142
Reaction Paths of Iron Oxidation and Hydrolysis in Horse Spleen and Recombinant Human Ferritins
Yang, X., Chen-Barrett, Y., Arosio, P., & Chasteen, N. D. (1998) · Biochemistry · doi:10.1021/bi973128a · Cited by 137
Wolf, C. R., Hayward, I. P., Lawrie, S. S., BUCKTON, K. E., McIntyre, M. A., Adams, D. J., Lewis, A. D., Scott, A. R. R., & Smyth, J. F. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390607 · Cited by 135
Protective effect of metallothionein on oxidative stress-induced DNA damage
Chiaverini, N., & LEY, M. D. (2010) · Free Radical Research · doi:10.3109/10715761003692511 · Cited by 134
Cited by
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomova, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,022
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Exploration of the medical periodic table: towards new targets
Barry, N. P. E., & Sadler, P. J. (2013) · Chemical Communications · doi:10.1039/c3cc41143e · Cited by 717
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Trondl, R., Heffeter, P., Kowol, C. R., Jakupec, M. A., Berger, W., & Keppler, B. K. (2014) · Chem. Sci. · doi:10.1039/c3sc53243g · Cited by 675
Self-citationNext-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Metadata
- Authors
- Jungwirth, U., Kowol, C. R., Keppler, B. K., Hartinger, C. G., Berger, W., & Heffeter, P.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-08-15
- Volume
- 15
- Issue
- 4
- Pages
- 1085-1127
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1985233650
- Cited by
- 554
- References
- 316
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.